Effects of Labetalol on Human Cocaine Use - 8
NCT00000291 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Labetalol
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-10-31
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacogenetics of Disulfiram for Cocaine
NCT00149630 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
NCT00051896 ·Status: UNKNOWN ·Phase: PHASE1
-
Naltrexone in Treatment of Cocaine Dependence - 5
NCT00015080 ·Status: COMPLETED ·Phase: PHASE2
-
Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 ·Status: COMPLETED ·Phase: PHASE2
-
n-Acetylcysteine and Cocaine
NCT02141620 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
CBT With Disulfiram and Contingency Management
NCT00350870 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Beta-blockade Effects on Memory for Cocaine Craving
NCT00830362 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Test Detection of Cocaine for Nasal Intubation
NCT05334056 ·Status: COMPLETED
-
Baclofen for the Treatment of Cocaine Dependence - 1
NCT00082485 ·Status: COMPLETED ·Phase: PHASE2
-
New Medication Treatment for Stimulant Dependence
NCT00689572 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
NCT00033111 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine
NCT00218166 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
NCT00158132 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Cocaine Dependence With Lisdexamfetamine
NCT00958282 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1
NCT00100113 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
NCT02393599 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
NCT03423667 ·Status: TERMINATED ·Phase: PHASE2
-
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916 ·Status: UNKNOWN ·Phase: PHASE1
-
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
NCT00368290 ·Status: COMPLETED ·Phase: PHASE2
-
Relapse Patterns in Female Cocaine Users - 4
NCT00000287 ·Status: COMPLETED
-
Cocaine in Parotid Saliva, Blood and Urine - 4
NCT00000190 ·Status: COMPLETED ·Phase: PHASE1